-+ 0.00%
-+ 0.00%
-+ 0.00%

GlucoTrack completes business combination with Lōkahi Therapeutics, creating Lōkahi-controlled public company

PUBT·07/14/2026 22:19:05
Listen to the news
GlucoTrack completes business combination with Lōkahi Therapeutics, creating Lōkahi-controlled public company
  • Glucotrack completed a strategic business combination with Lōkahi Therapeutics, creating a publicly listed platform controlled by Lōkahi.
  • Lōkahi became the operating and controlling business, using the public listing to support asset sourcing and late-stage clinical development.
  • Lōkahi securityholders received common stock and convertible preferred stock; conversion could leave them with about 90% fully diluted ownership.
  • A planned private placement financing is set to bolster capital, with part of proceeds earmarked for Glucotrack’s legacy CBGM technology.
  • The CBGM business will run as a wholly owned subsidiary with separate operations and capital structure; Erik Emerson named CEO, Paul Goode CTO and CBGM subsidiary CEO.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GlucoTrack Inc. published the original content used to generate this news brief on July 14, 2026, and is solely responsible for the information contained therein.